SOPHARMA (SPH) komunikat - Current report 105 buy back 09102014

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		105	/	2014
Date of issue:	2014-10-09
Short name of the issuer
SOPHARMA AD
Subject
Current report 105 buy back 09102014
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD hereby informs that from 2 October 2014 up to and including 8 October 2014 the Company bought 14 015 own shares representing 0.011% of the share capital of the Company, to the total value of 56 025.88 BGN on the Bulgarian Stock Exchange, the average price per share was 3.998 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 101 113, representing 3.86% of the share capital of the Company.
Annexes
File			Description
			Current report 105 buy back 09102014

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2014-10-09	Ognian Donev	Executive director

Konta:	Konta osobiste Konta młodzieżowe Konta firmowe Konta walutowe
Kredyty:	Kredyty gotówkowe Kredyty mieszkaniowe Kredyty z dopłatą Kredyty dla firm

Current report 105 buy back 09102014